Giorgia Quadrato, Ph.D.

Scientific Advisory Board Member

Dr. Quadrato's research focuses on understanding the cellular and molecular basis of human brain development and disease. By combining emerging models of the human brain with single-cell omics approaches, she aims to identify cell-type-specific disease mechanisms and, most importantly, new treatments for human neurodevelopmental disorders. Dr. Quadrato has received several awards, including the 2019 Donald E. and Delia B. Baxter Foundation Faculty Scholar Award, the 2020 Edward Mallinckdrot, Jr Foundation Early Career Faculty Award, and the 2023 Broad Innovation Award. Since 2024, she has been a member of the Scientific Advisory Board for the Syngap Research Fund (SRF).

Dr. Quadrato received her BS and MS in pharmacogenomic biotechnology from the University of Milano-Bicocca (Italy) and her PhD in Pharmaceutical Biotechnology from the University Amedeo Avogadro (Italy).

Paul Roma
Founder, Chief Executive Officer
David Margulies, M.D.
Founder, Chairman
Dave Liederbach
President
Graham Dempsey, Ph.D.
Founder, Chief Scientific Officer
David Gerber, Ph.D.
Consulting Senior Vice President Scientific Affairs
Matthew Sarbanis
Vice President of Finance
Owen McManus, Ph.D.
Consulting Chief Technology Officer
Luis Williams, Ph.D.
Vice President of Biology
Denise Johnson
Chief of Human Resources & Administration
Amy Elder, Ph.D.
Consulting Director of Chemistry
James Fink, Ph.D.
Senior Director, Epilepsy Therapeutics Lead
Yang Lu, Ph.D.
Associate Director, Head of Measurement Engineering
Steve Ryan, Ph.D.
Director, Head of Biomedical Data Science
Hongkang Zhang, Ph.D.
Senior Director, Pain Therapeutics Lead
Publications
Terms
Privacy
Contact
© 2024 Quiver Bioscience